Cortisol and DHEAS in COVID-19
- PMID: 36374475
- PMCID: PMC9660206
- DOI: 10.1007/s42000-022-00417-3
Cortisol and DHEAS in COVID-19
Conflict of interest statement
The authors declare no competing interests.
Comment on
-
Assessment of DHEAS, cortisol, and DHEAS/cortisol ratio in patients with COVID-19: a pilot study.Hormones (Athens). 2022 Sep;21(3):515-518. doi: 10.1007/s42000-022-00382-x. Epub 2022 Jul 8. Hormones (Athens). 2022. PMID: 35804262 Free PMC article.
References
-
- Yavropoulou MP, Filippa MG, Mantzou A, Ntziora F, Mylona M, Tektonidou MG, Vlachogiannis NI, Paraskevis D, Kaltsas GA, Chrousos GP, Sfikakis PP. Alterations in cortisol and interleukin-6 secretion in patients with COVID-19suggestive of neuroendocrine immune adaptations. Endocrine. 2022;75:317–327. doi: 10.1007/s12020-021-02968-8. - DOI - PMC - PubMed
-
- Tan T, Khoo B, Mills EG, Phylactou M, Patel B, Eng PC, Thurston L, Muzi B, Meeran K, Prevost AT, Comninos AN, Abbara A, Dhillo WS. Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 2020;8:659–660. doi: 10.1016/S2213-8587(20)30216-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical